NCT05572528View on ClinicalTrials.gov

Lenvatinib Therapy in HCC Patients After LDLT

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Liver TransplantationHepatocellular Carcinoma
Trial Locations (1)

83305

RECRUITING

Kaohsiung Cheng Gang, Kaohsiung City

All Listed Sponsors
lead

Kaoshiung Chang Gung Memorial Hospital

OTHER